Thyroid Gland: Diseases
(asked on 3rd February 2016) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps he plans to take in response to increases in the cost to the NHS of Liothyronine; and if he will make a statement.
This question was answered on 8th February 2016
The Government’s policy on generic medicines is to allow manufacturers freedom of pricing for their products, relying on competition to deliver value for money. Any potential pricing abuses are a matter for the Competition and Markets Authority (CMA). The Department is in regular contact with the CMA.